Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation
1 clinical trials · Condition
◉ Watch Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation
| Record | Firm | Date |
|---|---|---|
| A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation (NCT04296370) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-13 |
Track Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation automatically
Every clearance here is in the API, with alerts when new ones post.